Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2023 Filed Jan 30, 2023 17:02 UTC |
Reine AllanChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001562180-23-000722 · primarydocument.xml · derivative · entry 1 Reine Allan · CIK 0001714023 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-01-25 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:04 UTC |
Cavalie FannyChief Strategy/Bus Ops Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001562180-23-000727 · primarydocument.xml · derivative · entry 1 Cavalie Fanny · CIK 0001913484 · Chief Strategy/Bus Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2033-01-25 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:03 UTC |
Bellon Steven F.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001562180-23-000726 · primarydocument.xml · derivative · entry 1 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-01-25 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:03 UTC |
Costa CarlosChief People Officer
|
GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001562180-23-000725 · primarydocument.xml · derivative · entry 1 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2033-01-25 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:03 UTC |
LaCascia MichaelChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001562180-23-000724 · primarydocument.xml · derivative · entry 1 LaCascia Michael · CIK 0001831755 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-01-25 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| January 26, 2023 Filed Jan 30, 2023 22:02 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 280,000 | $0.00 Strike: $8.38 | $0.00 |
DisclosureSEC source: 0001562180-23-000723 · primarydocument.xml · derivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2033-01-25 F1 · derivative.exercise_date: The option vests as to 25% of the underlying shares of common stock on January 26, 2024, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 20:04 UTC |
Lynch Thomas J. Jr.Director
|
GrantStock Options (Right to buy) · Derivative | 32,000 | $8.23 Strike: $8.23 | $263,360.00 |
DisclosureSEC source: 0001562180-22-007379 · primarydocument.xml · derivative · entry 1 Lynch Thomas J. Jr. · CIK 0001474056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2032-10-26 F1 · derivative.exercise_date: The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors. Read SEC document |
| October 25, 2022 Filed Feb 22, 2023 21:23 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
OtherCommon Stock | 4,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001675 · primarydocument.xml · nonDerivative · entry 4 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 444,333 F1 · date: Reported late due to administrative error. F4 · kind: Transfer of assets between the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Reporting Person. F6 · ownership.nature: Consists of 295,629 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee. Read SEC document |
| October 25, 2022 Filed Feb 22, 2023 21:23 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
OtherCommon Stock | 4,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001675 · primarydocument.xml · nonDerivative · entry 3 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,371 F1 · date: Reported late due to administrative error. F4 · kind: Transfer of assets between the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, and the Reporting Person. F5 · balance_after: The reported holdings include 40,000 shares of the Issuer's Common Stock acquired by the Reporting Person through an option exercise reported on Form 4 on September 19, 2022. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 20:06 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001562180-22-006726 · primarydocument.xml · derivative · entry 3 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,925 Underlying: Common Stock · 40,000 shares Expires 2027-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on May 30, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 20:06 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 40,000 | $0.54 | $21,600.00 |
DisclosureSEC source: 0001562180-22-006726 · primarydocument.xml · nonDerivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 00:59 UTC |
GILL SIMBADirector
|
GiftCommon Stock | 47,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-006673 · primarydocument.xml · nonDerivative · entry 2 GILL SIMBA · CIK 0001180763 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,061 F1 · kind: Represents a bona fide gift of Common Stock to a non-profit educational institution. Read SEC document |
| September 12, 2022 Filed Sep 15, 2022 00:59 UTC |
GILL SIMBADirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 82,000 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001562180-22-006673 · primarydocument.xml · derivative · entry 3 GILL SIMBA · CIK 0001180763 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,188 Underlying: Common Stock · 82,000 shares Expires 2027-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on July 25, 2018, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option was fully vested. Read SEC document |
| September 12, 2022 Filed Sep 15, 2022 00:59 UTC |
GILL SIMBADirector
|
Exercise / conversionCommon Stock | 82,000 | $0.73 | $59,860.00 |
DisclosureSEC source: 0001562180-22-006673 · primarydocument.xml · nonDerivative · entry 1 GILL SIMBA · CIK 0001180763 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 23:09 UTC |
PARSHALL B LYNNEDirector
|
GrantStock Options (Right to buy) · Derivative | 32,000 | $16.34 Strike: $16.34 | $522,880.00 |
DisclosureSEC source: 0001562180-22-006232 · primarydocument.xml · derivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2032-08-15 F1 · derivative.exercise_date: The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 22:15 UTC |
Bellon Steven F.Chief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 1,858 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-22-006087 · primarydocument.xml · derivative · entry 3 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,716 Underlying: Common Stock · 1,858 shares Expires 2029-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 22:15 UTC |
Bellon Steven F.Chief Scientific Officer
|
Exercise / conversionCommon Stock | 1,858 | $3.72 | $6,911.76 |
DisclosureSEC source: 0001562180-22-006087 · primarydocument.xml · nonDerivative · entry 1 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 01:06 UTC |
Costa CarlosChief People Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $14.20 | $0.00 |
DisclosureSEC source: 0001562180-22-005891 · primarydocument.xml · derivative · entry 1 Costa Carlos · CIK 0001939167 · Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-07-31 F1 · derivative.exercise_date: The option will vest as to 25% of the underlying shares of common stock on August 1, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:59 UTC |
GILL SIMBADirector
|
GrantStock Options (Right to buy) · Derivative | 16,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001562180-22-005315 · primarydocument.xml · derivative · entry 1 GILL SIMBA · CIK 0001180763 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-20 Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 01:00 UTC |
Cole Douglas G.Director
|
GrantStock Options (Right to buy) · Derivative | 16,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001562180-22-005318 · primarydocument.xml · derivative · entry 1 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-20 Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 01:00 UTC |
SMITH IAN FDirector
|
GrantStock Options (Right to buy) · Derivative | 16,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001562180-22-005317 · primarydocument.xml · derivative · entry 1 SMITH IAN F · CIK 0001197032 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-20 Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:59 UTC |
Koppel AdamDirector
|
GrantStock Options (Right to buy) · Derivative | 16,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001562180-22-005314 · primarydocument.xml · derivative · entry 1 Koppel Adam · CIK 0001578965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-20 Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 01:00 UTC |
Biller ScottDirector
|
GrantStock Options (Right to buy) · Derivative | 16,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001562180-22-005320 · primarydocument.xml · derivative · entry 1 Biller Scott · CIK 0001581956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-20 Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 01:00 UTC |
Mendelsohn MichaelDirector
|
GrantStock Options (Right to buy) · Derivative | 16,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001562180-22-005319 · primarydocument.xml · derivative · entry 1 Mendelsohn Michael · CIK 0001591109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-20 Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 00:59 UTC |
KADOCH CIGALLDirector · 10% owner
|
GrantStock Options (Right to buy) · Derivative | 16,000 | $0.00 Strike: $13.81 | $0.00 |
DisclosureSEC source: 0001562180-22-005316 · primarydocument.xml · derivative · entry 1 KADOCH CIGALL · CIK 0001828726 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-06-20 Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:10 UTC |
Bellon Steven F.Chief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 3,717 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-22-004545 · primarydocument.xml · derivative · entry 5 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,574 Underlying: Common Stock · 3,717 shares Expires 2029-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:10 UTC |
Bellon Steven F.Chief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 675 | $0.00 Strike: $0.73 | $0.00 |
DisclosureSEC source: 0001562180-22-004545 · primarydocument.xml · derivative · entry 4 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 675 shares Expires 2028-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested at a rate of 6.25% of the underlying shares beginning on April 1, 2018 and thereafter on the first day of each calendar quarter until the option was fully vested. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:10 UTC |
Bellon Steven F.Chief Scientific Officer
|
Exercise / conversionCommon Stock | 3,717 | $3.72 | $13,827.24 |
DisclosureSEC source: 0001562180-22-004545 · primarydocument.xml · nonDerivative · entry 2 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:10 UTC |
Bellon Steven F.Chief Scientific Officer
|
Exercise / conversionCommon Stock | 675 | $0.73 | $492.75 |
DisclosureSEC source: 0001562180-22-004545 · primarydocument.xml · nonDerivative · entry 1 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 22, 2023 21:23 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 123,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001675 · primarydocument.xml · nonDerivative · entry 2 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 448,704 F1 · date: Reported late due to administrative error. F2 · kind: On February 10, 2022, the Reporting Person transferred 123,479 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration. F3 · ownership.nature: Consists of 300,000 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary, and 148,704 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee. Read SEC document |
| February 10, 2022 Filed Feb 22, 2023 21:23 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GiftCommon Stock | 123,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001675 · primarydocument.xml · nonDerivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 F1 · date: Reported late due to administrative error. F2 · kind: On February 10, 2022, the Reporting Person transferred 123,479 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:27 UTC |
Agresta SamuelChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001562180-22-000751 · primarydocument.xml · derivative · entry 1 Agresta Samuel · CIK 0001748961 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 16:26 UTC |
Reine AllanChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 135,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001562180-22-000748 · primarydocument.xml · derivative · entry 1 Reine Allan · CIK 0001714023 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:27 UTC |
Bellon Steven F.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001562180-22-000750 · primarydocument.xml · derivative · entry 1 Bellon Steven F. · CIK 0001831749 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:26 UTC |
LaCascia MichaelChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 135,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001562180-22-000749 · primarydocument.xml · derivative · entry 1 LaCascia Michael · CIK 0001831755 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:26 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 440,000 | $0.00 Strike: $14.87 | $0.00 |
DisclosureSEC source: 0001562180-22-000747 · primarydocument.xml · derivative · entry 3 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,000 Underlying: Common Stock · 440,000 shares Expires 2032-01-25 F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 00:20 UTC |
KADOCH CIGALLDirector · 10% owner
|
GiftCommon Stock | 333,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-007735 · primarydocument.xml · nonDerivative · entry 1 KADOCH CIGALL · CIK 0001828726 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,000 F1 · price: On December 14, 2021, the Reporting Person transferred 333,333 shares of Common Stock to the Cigall Kadoch Irrevocable Trust of 2021 (the "Irrevocable Trust"). The Reporting Person is not a trustee of the Irrevocable Trust and she exercises no investment discretion with respect to trust property therein. The Reporting Person and members of her immediate family are beneficiaries of the Irrevocable Trust. Read SEC document |
| December 09, 2021 Filed Dec 14, 2021 01:37 UTC |
DECICCO CARLChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 27,418 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-21-007666 · primarydocument.xml · derivative · entry 3 DECICCO CARL · CIK 0001828727 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,273 Underlying: Common Stock · 27,418 shares Expires 2029-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| December 09, 2021 Filed Dec 14, 2021 01:37 UTC |
DECICCO CARLChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 76,892 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-21-007666 · primarydocument.xml · derivative · entry 2 DECICCO CARL · CIK 0001828727 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,571 Underlying: Common Stock · 76,892 shares Expires 2029-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on December 10, 2019, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| December 09, 2021 Filed Dec 14, 2021 01:37 UTC |
DECICCO CARLChief Scientific Officer
|
Exercise / conversionCommon Stock | 104,310 | $3.72 | $388,033.20 |
DisclosureSEC source: 0001562180-21-007666 · primarydocument.xml · nonDerivative · entry 1 DECICCO CARL · CIK 0001828727 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 21:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 23,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001562180-21-005521 · primarydocument.xml · derivative · entry 3 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,925 Underlying: Common Stock · 23,000 shares Expires 2027-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on May 30, 2018, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| August 20, 2021 Filed Aug 23, 2021 21:01 UTC |
GOTTSCHALK ADRIANDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 23,000 | $0.54 | $12,420.00 |
DisclosureSEC source: 0001562180-21-005521 · primarydocument.xml · nonDerivative · entry 1 GOTTSCHALK ADRIAN · CIK 0001828724 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:14 UTC |
Reine AllanChief Financial Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 26,892 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001562180-21-005284 · primarydocument.xml · derivative · entry 2 Reine Allan · CIK 0001714023 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,512 Underlying: Common Stock · 26,892 shares Expires 2029-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 16:14 UTC |
Reine AllanChief Financial Officer
|
Exercise / conversionCommon Stock | 26,892 | $3.72 | $100,038.24 |
DisclosureSEC source: 0001562180-21-005284 · primarydocument.xml · nonDerivative · entry 1 Reine Allan · CIK 0001714023 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:53 UTC |
GILL SIMBADirector
|
GrantStock Option (right to buy) · Derivative | 12,530 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001562180-21-004933 · primarydocument.xml · derivative · entry 1 GILL SIMBA · CIK 0001180763 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,530 Underlying: Common Stock · 12,530 shares Expires 2031-07-12 F1 · derivative.exercise_date: The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:52 UTC |
Cole Douglas G.Director
|
GrantStock Option (right to buy) · Derivative | 12,530 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001562180-21-004932 · primarydocument.xml · derivative · entry 1 Cole Douglas G. · CIK 0001486373 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,530 Underlying: Common Stock · 12,530 shares Expires 2031-07-12 F1 · derivative.exercise_date: The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:53 UTC |
Koppel AdamDirector
|
GrantStock Option (right to buy) · Derivative | 12,530 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001562180-21-004935 · primarydocument.xml · derivative · entry 1 Koppel Adam · CIK 0001578965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,530 Underlying: Common Stock · 12,530 shares Expires 2031-07-12 F1 · derivative.exercise_date: The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:52 UTC |
Biller ScottDirector
|
GrantStock Option (right to buy) · Derivative | 12,530 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001562180-21-004931 · primarydocument.xml · derivative · entry 1 Biller Scott · CIK 0001581956 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,530 Underlying: Common Stock · 12,530 shares Expires 2031-07-12 F1 · derivative.exercise_date: The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:54 UTC |
Mendelsohn MichaelDirector
|
GrantStock Option (right to buy) · Derivative | 12,530 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001562180-21-004936 · primarydocument.xml · derivative · entry 1 Mendelsohn Michael · CIK 0001591109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,530 Underlying: Common Stock · 12,530 shares Expires 2031-07-12 F1 · derivative.exercise_date: The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors. Read SEC document |
| July 13, 2021 Filed Jul 14, 2021 20:53 UTC |
KADOCH CIGALLDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 12,530 | $0.00 Strike: $9.40 | $0.00 |
DisclosureSEC source: 0001562180-21-004934 · primarydocument.xml · derivative · entry 1 KADOCH CIGALL · CIK 0001828726 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,530 Underlying: Common Stock · 12,530 shares Expires 2031-07-12 F1 · derivative.exercise_date: The options will vest in full on the first anniversary of the date of grant, subject to the director's continued service on our Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.